ADR Trading Halt
June 17 2004 - 1:04PM
UK Regulatory
RNS Number:8943Z
Celltech Group PLC
17 June 2004
Celltech Group plc (symbol: CLL) announces today that it has received
notification from the New York Stock Exchange (the "NYSE") that, in accordance
with its standard operating procedures, the NYSE intends to halt trading of
Celltech's American Depositary Receipts as of 10:00 a.m. (New York City time)
today as such time is the close of the initial offer period for the recommended
cash tender offer by UCB S.A. for the entire issued share capital of Celltech.
Celltech has been informed that the halt of trading shall continue until such
time as UCB makes public announcement of the level of acceptances as of the
close of the initial offer period and its intention whether to extend the
initial offer period or commence the subsequent offer period. In accordance with
the provisions of the U.K. City Code on Takeovers and Mergers and the Securities
Exchange Act of 1934 and as set out in the Offer Document dated May 19, 2004,
UCB intends to make such announcement no later than 8:00 a.m. (London time) in
the United Kingdom, and by 8:00 a.m. (New York City time) in the United States,
on June 18, 2004.
Enquiries:
Richard Bungay Director of Corporate Communications+44 (0)1753 534655
John Slater Company Secretary+44 (0)1753 534655
END
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCILFERRAIDLIS
Coca-cola Hbc (LSE:CCH)
Historical Stock Chart
From Jul 2024 to Aug 2024
Coca-cola Hbc (LSE:CCH)
Historical Stock Chart
From Aug 2023 to Aug 2024